apollo
0
  1. Home
  2. Medicine
  3. Baraclude 0.5 mg Oral Solution 210 ML

Written By Veda Maddala , M Pharmacy
Reviewed By Bayyarapu Mahesh Kumar , M Pharmacy
Non returnable*
COD available

Online payment accepted

rxMedicinePrescription drug

Whats That

tooltip

Composition :

ENTECAVIR-0.05MG

Manufacturer/Marketer :

Bristol-Myers Squibb India Pvt Ltd

Consume Type :

ORAL

Return Policy :

Not Returnable

Expires on or after :

About Baraclude 0.5 mg Oral Solution

Baraclude 0.5 mg Oral Solution belongs to a class of drugs called antivirals used to treat chronic hepatitis B virus (HBV) infection. Hepatitis B is a severe liver infection caused by the hepatitis B virus (HBV). It is highly contagious (spreads from one person to another) and spreads through intimate contact with the infected person, direct contact with infected blood, being pricked with a contaminated needle, using a razor or any other personal items with leftovers of infected fluid or even transfer from mother to baby during birth.

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug that works by inhibiting viral DNA polymerase enzyme action in the liver cells that is essential for the virus to multiply. Thereby, it stops the virus from making new viruses and reduces the amount of hepatitis B virus in the body.

Take Baraclude 0.5 mg Oral Solution as prescribed by your doctor. You are advised to take Baraclude 0.5 mg Oral Solution for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience dizziness, headache, nausea, vomiting, drowsiness, extreme tiredness, insomnia (inability to sleep), diarrhoea, or indigestion. Most of these side effects of Baraclude 0.5 mg Oral Solution do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Baraclude 0.5 mg Oral Solution or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, please consult a doctor before taking Baraclude 0.5 mg Oral Solution . It is recommended to use effective contraceptive methods while using Baraclude 0.5 mg Oral Solution to avoid pregnancy. Baraclude 0.5 mg Oral Solution is not recommended for children below 2 years of age. If you experience stomach pain, vomiting, or nausea while taking Baraclude 0.5 mg Oral Solution , it might indicate lactic acidosis development. This rare but serious side effect has occasionally been fatal. Lactic acidosis occurs more often in women, particularly if they are very overweight. Your doctor will monitor you regularly while you are receiving. If you have HIV/AIDS, kidney or liver problems, inform your doctor before taking Baraclude 0.5 mg Oral Solution .

Uses of Baraclude 0.5 mg Oral Solution

Chronic hepatitis B virus (HBV) infection

Directions for Use

Baraclude 0.5 mg Oral Solution can be taken on an empty stomach, preferably 2 hours before or after a meal. Tablet: It should be swallowed as a whole with a glass of water. Do not break, crush or chew it. Oral solution: It should be taken by mouth using the measuring cup provided with the pack. Shake the bottle well before each use.

Medicinal Benefits

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug used to treat chronic hepatitis B virus (HBV) infection. Baraclude 0.5 mg Oral Solution works by inhibiting viral DNA polymerase enzyme action in the liver cells that is essential for the virus to multiply. Thereby, it stops the virus from making new viruses and reduces the amount of hepatitis B virus in the body. Thus, decreases damage to the liver and improves liver functioning.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

If you are allergic to Baraclude 0.5 mg Oral Solution or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, please consult a doctor before taking Baraclude 0.5 mg Oral Solution . It is recommended to use effective contraceptive methods while using Baraclude 0.5 mg Oral Solution to avoid pregnancy. Baraclude 0.5 mg Oral Solution is not recommended for children below 2 years of age. You are advised to take proper precautions if you are infected with hepatitis B virus infection to prevent infection spread to others through sexual contact or body fluids. Hepatitis B vaccine should be taken to prevent Hepatitis B virus infection. If you experience stomach pain, vomiting or nausea while taking Baraclude 0.5 mg Oral Solution , it might indicate lactic acidosis development. This rare but serious side effect has occasionally been fatal. Lactic acidosis occurs more often in women, particularly if they are very overweight. Your doctor will monitor you regularly while you are receiving. If you have HIV/AIDS, kidney or liver problems, inform your doctor before taking Baraclude 0.5 mg Oral Solution .

Diet & Lifestyle Advise

  • Include plenty of vegetables and fruits, and whole grains such as brown rice, oats, quinoa, and barley.
  • Eat lean protein such as skinless chicken, fish, beans, and egg whites.
  • Include healthy fats like avocados, olive oil, and nuts.
  • Eat low-fat or non-fat dairy products to minimize damage to the liver.
  • Drink plenty of water for better processing of food by the body.
  • Avoid sugary foods such as cake, cookies, packaged baked food, or soda. Also, avoid heavy salt foods.
  • Avoid foods containing saturated fats such as fried foods, fatty cuts of meat, sour cream, butter, and other high-fat dairy products as they may lead to weight gain and result in fatty liver.
  • Avoid smoking and alcohol consumption as they may increase the risk of liver damage.

Habit Forming

No

Therapeutic Class

ANTIVIRALS

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug that works by preventing viral DNA polymerase enzyme action in the liver cells that is essential for the virus to multiply. Thereby, it stops the virus from making new viruses and reduces the amount of hepatitis B virus in the body.

Yes, hepatitis B virus infection is highly contagious and spreads from one person to another. Therefore, it is recommended to avoid sharing personal items or needles containing an infected person's blood or body fluids.

Baraclude 0.5 mg Oral Solution may cause lactic acidosis (excess of lactic acid in the blood), a rare but a severe side effect, especially in women who are very obese. However, if you experience stomach pain, vomiting or nausea while taking Baraclude 0.5 mg Oral Solution , please consult a doctor immediately.

You are not recommended to take Baraclude 0.5 mg Oral Solution with celecoxib (painkiller), as it may increase the blood levels of Baraclude 0.5 mg Oral Solution , leading to more adverse effects and may also affect kidney function. However, please consult your doctor before taking Baraclude 0.5 mg Oral Solution with other medicines.

Baraclude 0.5 mg Oral Solution does not cure hepatitis B virus infection. Baraclude 0.5 mg Oral Solution reduces the amount of hepatitis B virus in the body and improves liver functioning by decreasing liver damage.

Baraclude 0.5 mg Oral Solution is not recommended for hepatitis B patients with HIV infection unless they are taking medicines to treat HIV infection at the same time as Baraclude 0.5 mg Oral Solution may cause HIV infection to become resistant to certain HIV drugs and reduce their effectiveness. Therefore, it is advised to get tested for HIV infection before taking Baraclude 0.5 mg Oral Solution .

You are not recommended to stop taking Baraclude 0.5 mg Oral Solution without consulting your doctor as it may worsen the infection or cause recurring symptoms. Therefore, take Baraclude 0.5 mg Oral Solution for as long as your doctor has prescribed it, and if you experience any difficulty while taking Baraclude 0.5 mg Oral Solution , please consult your doctor.

Drug-Drug Interactions Checker List

  • CELECOXIB
  • ZOLEDRONIC ACID

Special Advise

Regular blood tests are recommended while taking Baraclude 0.5 mg Oral Solution and several months after treatment with Baraclude 0.5 mg Oral Solution to monitor liver functioning.

Disease/Condition Glossary

Hepatitis B: It is a severe liver infection caused by the hepatitis B virus (HBV). It is highly contagious (spreads from one person to another) and spreads through intimate contact with the infected person, direct contact with infected blood, being pricked with a contaminated needle, using a razor or any other personal items with leftovers of infected fluid or even transfer from mother to baby during birth. The virus can live for up to 7 days outside the body. Chronic hepatitis B develops slowly, and the symptoms may not be clear unless complications develop. The symptoms of hepatitis B may appear after 3 months of exposure to the virus and can last for 2 to 12 weeks. The complications of chronic hepatitis B include liver failure, liver cancer or liver cirrhosis (scarring). Hepatitis B can be prevented by taking the vaccination.

Have a query?

whatsapp Floating Button